Business Wire

QUECTEL-WIRELESS

26.6.2024 13:01:27 CEST | Business Wire | Press release

Share
Quectel Unveils FLM263D Wi-Fi Module: Pioneering Seamless Connectivity with ACK SDK for Matter

Quectel Wireless Solutions, a global IoT solutions provider, announced the launch of the FLM263D standalone Wi-Fi module that supports Alexa Connect Kit (ACK) SDK for Matter, enabling IoT devices to connect seamlessly with Matter compliant controllers including Amazon Alexa, Google Home, Samsung SmartThings, and Apple HomeKit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626747648/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Quectel unveils FLM263D Wi-Fi module: Pioneering seamless connectivity with ACK SDK for Matter (Photo: Business Wire)

Matter stands as a pivotal standard in smart home communication, tackling the persistent challenges of compatibility and fragmentation within the sector by enabling direct communication between smart devices. Governed by the Connectivity Standards Alliance (CSA), Matter devices undergo a stringent certification process to ensure secure, reliable, and universally interoperable connections. Adherence to this certification is paramount for all Matter-compliant products, fostering a unified communication framework and enhancing user experiences.

“We created ACK to make it simpler for device makers to build smart home devices with a fully-managed service without having deep expertise in multiple wireless protocols, complex cloud connectivity, and the necessary maintenance of cloud infrastructure. We are excited about this launch because Quectel’s FLM263D adds to ACK's portfolio of available solutions and offers more choices for device makers,” says Ben McInnis, Director, Smart Home, Amazon.

“Revolutionizing connectivity in the smart home landscape, our latest FLM263D module sets a new standard for seamless integration,” commented Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “It also empowers developers with robust support for the ACK SDK for Matter, ensuring unparalleled interoperability and innovation in the IoT ecosystem.”

The FLM263D module is a 2.4GHz single band Wi-Fi 6 module, featuring a high-performance processor with a frequency of up to 320MHz. This innovative module boasts support for IEEE 802.11b/g/n/ax protocol and BLE 5.2, paired with built-in 512KB SRAM and 4MB flash for optimal performance. Furthermore, it meets rigorous security standards, including secure boot and mbed TLS encryption, ensuring robust protection for connected devices.

The FLM263D offers support for device certifications such as Works with Alexa (WWA) and features such as Matter Simple Setup (MSS). MSS allows end-users to seamlessly connect Matter-compliant smart home devices to Alexa with zero-touch setup, while WWA instils consumer confidence when buying on Amazon.

FLM263D offers five GPIO interfaces that can alternatively function as PWM or I2C communication channels. Designed with an LCC form factor, built-in PCB antenna, measuring a mere 17.3mm × 15.0mm × 2.8mm, and with an operating temperature range of -40°C to +105°C, 3.0~3.6V power supply, the FLM263D is perfectly suited for smart lighting applications, especially smart bulbs.

Additional modules will be rolled out very soon to expand the scope of Quectel offerings to include smart switches, smart plugs, and other smart household applications.

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240626747648/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HTEC Research: Only One in Three Healthcare Organizations is Ready to Scale AI28.4.2026 15:22:00 CEST | Press release

Healthcare and life sciences leaders are advancing AI with caution—fragmentation, capability gaps, and execution challenges are slowing enterprise-wide impact AI is already embedded across healthcare and life sciences. Most organizations are deploying it, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428872907/en/ HTEC, a global AI‑first provider of software and hardware design and engineering services, today released new research based on a global survey of 253 C-level HLS executives across the United States, United Kingdom, Germany, Spain, Saudi Arabia, and the UAE. AI is already embedded across healthcare and life sciences. Most organizations are deploying AI, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. HTEC, a global AI‑first provider of software and hardware design a

JPMorganChase Named First-Ever Global Banking Partner of the Olympic Games28.4.2026 15:00:00 CEST | Press release

International Olympic Committee and JPMorganChase Announce Landmark Global Olympic Partnership The International Olympic Committee (IOC) and JPMorganChase today announced a landmark Worldwide Olympic Partnership, making JPMorganChase the first Global Banking Partner in Olympic history. The partnership includes the Los Angeles 2028 Olympic and Paralympic Games (LA28 Games) and the French Alps 2030 Olympic and Paralympic Winter Games. The firm has also reached an agreement with LA28 to become the Official Bank of Team USA and LA28, and a Founding Partner of the LA28 Games. The partnership reflects a shared commitment to ambition and excellence, and places athletes and communities at its core. Kirsty Coventry, President of the IOC, commented: “JPMorganChase is the first Global Partner from the banking sector in Olympic history, and we are proud to welcome them to the Worldwide Olympic Partner programme. This partnership reflects our shared values of ambition, excellence and will support t

BlueSnap, Powered by Payroc, Launches Local Acquiring in New Zealand to Boost Approval Rates and Reduce Cross-Border Costs28.4.2026 15:00:00 CEST | Press release

BlueSnap, powered by Payroc, today announced the availability of local acquiring in New Zealand, expanding its global payment orchestration capabilities and enabling businesses to process transactions domestically. Local acquiring allows businesses with a legal entity in New Zealand to process payments through domestic acquiring banks rather than routing transactions cross-border. This helps increase authorization rates, reduce payment failures, and lower transaction costs, critical factors for businesses selling into the region. Why Local Acquiring in New Zealand Matters For B2B and B2C businesses operating globally, cross-border payments often lead to higher fees and lower approval rates. Building local acquiring infrastructure independently requires managing multiple bank relationships, compliance, and integrations, making it costly and complex. BlueSnap simplifies this by providing local acquiring through a single platform, allowing businesses with a legal entity in New Zealand to

Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder28.4.2026 14:42:00 CEST | Press release

Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi

Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 14:28:00 CEST | Press release

CTIBIOTECH™, a leading innovator in advanced human tissue engineering, proudly announces CTIONCOTEST™ platform is awarded Major Bpifrance Funding to Industrialize 3D Bioprinted Cancer Models CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the pla

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye